TY  - GEN
AU  - Lyrdal,David
AU  - Stierner,Ulrika
AU  - Lundstam,Sven
TI  - Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b
SN  - 1651-226X
PY  - 2010///0202
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Kidney Neoplasms
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Polyethylene Glycols
KW  - Prognosis
KW  - Recombinant Proteins
KW  - Risk Factors
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - metabolism
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/02841860902795257
ER  -